Chapter 68: Hepatobiliary Disease References

Updated February 2011

Aguirre A, Yoshimura N, Westman T, et al. Plasma amino acid concentrations in dogs with two experimental forms of liver damage. Journal of Surgical Research 1974; 16: 339-345.

Anderson WD, Anderson BG. Atlas of Canine Anatomy. Philadelphia, PA: Lea & Febiger, 1994; 697-703.

Andersson M, Sevelius E. Circulating autoantibodies in dogs with chronic liver disease. Journal of Small Animal Practice 1992; 33: 389-394.

Armstrong PJ, Hardie EM, Cullen JM, et al. L-carnitine reduces hepatic fat accumulation during rapid weight reduction in cats (abstract). In: Proceedings. Tenth Annual Veterinary Medical Forum, American College of Veterinary Internal Medicine, San Diego, CA, 1992: 810.

Armstrong PJ, Weiss DJ, Gagne JM. Inflammatory liver disease. In: August JR, ed. Consultations in Feline Internal Medicine 3. Philadelphia, PA: WB Saunders Co, 1997; 68-78.

Barclay LRC, Locke SJ, MacNeil JM. Autooxidation in micelles. Synergism of vitamin C with lipid-soluble vitamin E and water soluble Trolox. Canadian Journal of Chemistry 1985; 63: 366-374.

Barr F. Diagnostic Ultrasound in the Dog and Cat. Oxford, UK: Blackwell Scientific Publications, 1990; 21-45.

Barsanti J, Jones B, Spano J, et al. Prolonged anorexia associated with hepatic lipidosis in three cats. Feline Practice 1977; 7: 52-57.

Bauer JE, Schenck PA. Nutritional management of hepatic disease. Veterinary Clinics of North America: Small Animal Practice 1989; 19: 513-526.

Bauer JE. Hepatic disease, nutritional therapy, and the metabolic environment. Journal of the American Veterinary Medical Association 1996; 209: 1850-1854.

Bauer JE. Nutrition and liver function: Nutrient metabolism in health and disease. Compendium on Continuing Education for the Practicing Veterinarian 1986; 8: 923-931.

Bianchi GP, Marchesini G, Fabbri A, et al. Vegetable versus animal protein diet in cirrhotic patients with chronic encephalopathy: A random crossover comparison. Journal of Internal Medicine 1993; 233: 385-392.

Biourge V, Groff JM, Fisher C, et al. Nitrogen balance, plasma free amino acid concentrations and urinary orotic acid excretion during long-term fasting in cats. Journal of Nutrition 1994; 124: 1094-1103.

Biourge V, MacDonald MJ, King L. Feline hepatic lipidosis: Pathogenesis and nutritional management. Compendium on Continuing Education for the Practicing Veterinarian 1990; 12: 1244-1258.

Biourge V, Massat B, Groff JM, et al. Effects of protein, lipid, or carbohydrate supplementation on hepatic lipid accumulation during rapid weight loss in obese cats. American Journal of Veterinary Research 1994a; 55: 1406-1415.

Biourge V, Pion P, Lewis J, et al. Spontaneous occurrence of hepatic lipidosis in a group of laboratory cats. Journal of Veterinary Internal Medicine 1993; 7: 194-197.

Biourge V. Nutrition and liver disease. Seminars in Veterinary Medicine and Surgery: Small Animal 1997; 12: 34-44.

Blackburn GL, O'Keefe SJD. Nutrition in liver failure. Gastroenterology 1989; 97: 1049-1051.

Blanchard G. Carnitine and feline hepatic lipidosis. In: L-Carnitine. "What difference does it make?" Hill's Symposium Proceedings. Leuven, Belgium. December 15, 1999: 30-31.

Brewer GJ, Dick RD, Schall W, et al. Use of zinc acetate to treat copper toxicosis in dogs. Journal of the American Veterinary Medical Association 1992; 201: 564-568.

Brewer GJ, Schall WD, Padgett GA, et al. The role of genetic and dietary factors and zinc therapy in copper toxicosis in dogs. Morris Animal Foundation Progress Report, September 1989.

Brewer GJ. Zinc in the treatment of Wilson's disease: How it works (Letter to the Editor). Gastroenterology 1993; 104: 1568.

Britton RS. Metal-induced hepatotoxicity. Seminars in Liver Disease 1996; 16(1): 3-11.

Bucher NLR, Malt RA. Regeneration of Liver and Kidney. Boston, MA: Little, Brown and Co, 1971; 143-176.

Bunch SE, Johnson SE, Cullen JM. Idiopathic noncirrhotic portal hypertension in dogs: 33 cases (1982-1998). Journal of the American Veterinary Medical Association 2001; 218(3): 392-399.

Center SA, Baldwin BH, Dillingham S, et al. Diagnostic value of serum gamma glutamyl transferase and alkaline phosphatase activities in hepatobiliary disease in the cat. Journal of the American Veterinary Medical Association 1986; 188: 507.

Center SA, Crawford MA, Guida L, et al. A retrospective study of 77 cats with severe hepatic lipidosis: 1975-1990. Journal of Veterinary Internal Medicine 1993; 7: 349-359.

Center SA, Reynolds AP, Harte J, et al. Clinical effects of rapid weight loss in obese pet cats with and without supplemental L-carnitine (abstract). In: Proceedings. Fifteenth Annual Veterinary Medical Forum, American College of Veterinary Internal Medicine, Lake Buena Vista, FL, 1997: 665.

Center SA, Strombeck DR. Liver: Normal structure and function. In: Guilford WG, Center SA, Strombeck DR, et al, eds. Strombeck's Small Animal Gastroenterology, 3rd ed. Philadelphia, PA: WB Saunders Co, 1996; 540-552.

Center SA. Chronic liver diseases. In: Guilford WG, Center SA, Strombeck DR, et al, eds. Strombeck's Small Animal Gastroenterology, 3rd ed. Philadelphia, PA: WB Saunders Co, 1996a; 705-765.

Center SA. Diagnostic procedures for evaluation of hepatic disease. In Guilford WG, Center SA, Strombeck DR, et al, eds. Strombeck's Small Animal Gastroenterology, 3rd ed. Philadelphia, PA: WB Saunders Co, 1996e; 130-179.

Center SA. Diseases of the gallbladder and biliary tree. In: Guilford WG, Center SA, Strombeck DR, et al, eds. Strombeck's Small Animal Gastroenterology, 3rd ed. Philadelphia, PA: WB Saunders Co, 1996d; 860-888.

Center SA. Hepatic lipidosis, glucocorticoid hepatopathy, vacuolar hepatopathy, storage disorders, amyloidosis and iron toxicity. In: Guilford WG, Center SA, Strombeck DR, et al, eds. Strombeck's Small Animal Gastroenterology, 3rd ed. Philadelphia, PA: WB Saunders Co, 1996c; 766-782.

Center SA. Hepatic vascular diseases. In: Guilford WG, Center SA, Strombeck DR, et al, eds. Strombeck's Small Animal Gastroenterology, 3rd ed. Philadelphia, PA: WB Saunders Co, 1996b; 802-833.

Center SA. Nutritional support for dogs and cats with hepatobiliary disease. Journal of Nutrition 1998; 128 (Suppl.): 2733S-2746S.

Center SA. Pathophysiology of liver disease: Normal and abnormal function. In: Guilford WG, Center SA, Strombeck DR, et al, eds. Strombeck's Small Animal Gastroenterology, 3rd ed. Philadelphia, PA: WB Saunders Co, 1996; 553-632.

Center SA. Pathophysiology, laboratory diagnosis, and diseases of the liver. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine, 4th ed. Philadelphia, PA: WB Saunders Co, 1995; 1261-1312.

Chang EB, Sitrin MD, Black DB. Gastrointestinal, Hepatobiliary, and Nutritional Physiology. Philadelphia, PA: Lippincott-Raven Publishers, 1996; 245-263.

Christiansen JS, Hottinger HA, Allen L, et al. Hepatic microvascular dysplasia in dogs: A retrospective study of 24 cases. Journal of the American Animal Hospital Association 2000; 36: 385-389.

Cole TL, Center SA, Flood SN, et al. Diagnostic comparison of needle and wedge biopsy specimens of the liver in dogs and cats. Journal of the American Veterinary Medical Association 2002; 220: 1483-1490.

Cornelius LM, Jacobs G. Feline hepatic lipidosis. In: Kirk RW, ed. Current Veterinary Therapy X. Philadelphia, PA: WB Saunders Co, 1989; 869-873.

Cullen JM, Popp JA. Tumors of the liver and gall bladder. In: Meuten DJ, ed. Tumors in Domestic Animals, 4th ed. Ames, IA: Iowa State Press, 2002; 483-508.

Day DG. Feline cholangiohepatitis complex. Veterinary Clinics of North America: Small Animal Practice 1995; 25: 375-385.

Dial SM. Clinicopathologic evaluation of the liver. Veterinary Clinics of North America: Small Animal Practice 1995; 25: 257-273.

Diehl AM. Nutrition, hormones, metabolism, and liver regeneration. Seminars in Liver Disease 1991; 11: 315-320.

Dimski DS, Taboada J. Feline idiopathic hepatic lipidosis. Veterinary Clinics of North America: Small Animal Practice 1995; 25: 357-373.

Drinker K, Thompson P, Marsh M. An investigation of the effect of long-continued ingestion of zinc, in the form of zinc oxide, by cats and dogs, together with observations upon the excretion and storage of zinc. American Journal of Physiology 1927; 80: 31-64.

Fischer JE, Funovics JM, Aguirre A, et al. The role of plasma amino acids in hepatic encephalopathy. Surgery 1975; 78: 276-290.

Francavilla A, Panella C, Polimeno L, et al. Hormonal and enzymatic parameters of hepatic regeneration in patients undergoing major liver resections. Hepatology 1990; 12: 1134-1138.

Friedman LS. Zinc in the treatment of Wilson's disease: How it works (Letter to the Editor). Gastroenterology 1993; 104: 1568.

Gaetke LM, Chow CK. Copper toxicity, oxidative stress, and antioxidant nutrients. Toxicology 2003; 189: 147-163.

Gagne JM, Armstrong PJ, Weiss DJ, et al. Clinical features of inflammatory liver disease in cats: 41 cases (1983-1993). Journal of the American Veterinary Medical Association 1999; 214: 513-516.

Gary AT, Twedt DC. Evaluation of elevated serum alkaline phosphatase in the dog. In: Bonagura JD, Twedt DC, eds. Kirk's Current Veterinary Therapy XIV. St. Louis, Mo: Saunders Elsevier, 2009; 549-553.

Gross TL, O'Brien TD, Davies AP, et al. Glucagon-producing pancreatic tumors in two dogs with superficial necrolytic dermatitis. Journal of the American Veterinary Medical Association 1990; 197(12): 1619-1622.

Gross TL, Song MD, Havel PJ, et al. Superficial necrolytic dermatitis (necrolytic migratory erythema) in dogs. Veterinary Pathology 1993; 30(1): 75-81.

Guilford WG. Nutritional management of gastrointestinal diseases. In: Guilford WG, Center SA, Strombeck DR, et al, eds. Strombeck's Small Animal Gastroenterology, 3rd ed. Philadelphia, PA: WB Saunders Co, 1996; 889-910.

Harrison SA, Torgerson S, Hayashi P, et al. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis American Journal of Gastroenterology 2003; 98: 2485-2490.

Harvey AM, Gruffydd-Jones TJ. Feline inflammatory liver disease. In: Ettinger SJ, Feldman EC, eds. St. Louis, MO: Elsevier Saunders, 2010; 1643-1648.

Haywood S, Rutgers HC, Christian MK. Hepatitis and copper accumulation in Skye terriers. Veterinary Pathology 1988; 25: 408-414.

Higgins GM, Anderson RM. Experimental pathology of the liver: Restoration of the liver by the white rat following partial surgical removal. Archives of Pathology 1931; 12: 186-202.

Hoffmann G, van den Ingh TS, Bode P, et al. Copper-associated chronic hepatitis in Labrador retrievers, Journal of Veterinary Internal Medicine 2006, 20: 856-861.

Hultgren BD, Stevens JB, Hardy RM. Inherited, chronic, progressive hepatic degeneration in Bedlington terriers with increased copper concentrations: Clinical and pathologic observations and comparison with other copper-associated liver diseases. American Journal of Veterinary Research 1986; 47: 365-377.

Jacobs G, Cornelius L, Keene B, et al. Comparison of plasma, liver, and skeletal muscle carnitine concentrations in cats with idiopathic hepatic lipidosis and in healthy cats. American Journal of Veterinary Research 1990; 51: 1349-1351.

Jewell DE, Toll PW, Wedekind KJ, et al. Effect of increasing dietary antioxidants on concentrations of vitamin E and total alkenals in serum of dogs and cats. Veterinary Therapeutics 2000; 1(4): 264-272.

Johnson GF, Zawie DA, Gilbertson SR, et al. Chronic active hepatitis in Doberman pinschers. Journal of the American Veterinary Medical Association 1982; 180: 1438-1442.

Justin RB, Hohenhaus AE. Hypophosphatemia associated with enteral alimentation in cats. Journal of Veterinary Internal Medicine 1995; 9: 228-233.

Kerwin SC. Hepatic aspiration and biopsy techniques. Veterinary Clinics of North America: Small Animal Practice 1995; 25: 275-291.

Laflamme DP, Allen SW, Huber TL. Apparent dietary protein requirement of dogs with portosystemic shunt. American Journal of Veterinary Research 1993; 54: 719-723.

Laflamme DP, Mahaffey EA, Allen SW, et al. Microcytosis and iron status in dogs with surgically induced portosystemic shunts. Journal of Veterinary Internal Medicine 1994, 8(3): 212-216.

Lamb CS. Ultrasonography of portosystemic shunts in dogs and cats. Veterinary Clinics of North America: Small Animal Practice 1998; 28: 725-753.

Latfi R, Killam RW, Dudrick SJ. Nutritional support in liver failure. Surgical Clinics of North America 1991; 71: 567-578.

Leevy CM, Thompson A, Baker H. Vitamins and liver injury. American Journal of Clinical Nutrition 1982; 35: 56-72.

Lisciandro SC, Hohenhaus A, Brooks M. Coagulation abnormalities in 22 cats with naturally occurring liver disease. Journal of Veterinary Internal Medecine 1998; 12(2): 71-75.

Maddison JE. Hepatic encephalopathy: Current concepts of the pathogenesis. Journal of Veterinary Internal Medicine 1992; 6: 341-353.

Mandigers PJ, van den Ingh TS, Bode P, et al. Improvement in liver pathology after 4 months of D-penicillamine in 5 Doberman pinschers with subclinical hepatitis. Journal of Veterinary Internal Medicine 2005; 19: 40-43.

Marks SL, Rogers QR, Strombeck DR. Nutritional support in hepatic disease. Part I. Metabolic alterations and nutritional considerations in dogs and cats. Compendium on Continuing Education for the Practicing Veterinarian 1994; 16: 971-978.

Marks SL, Rogers QR, Strombeck DR. Nutritional support in hepatic disease. Part II. Dietary management of common liver disorders in dogs and cats. Compendium on Continuing Education for the Practicing Veterinarian 1994a; 16: 1287-1295.

McCullough AJ, Tavill AS. Disordered energy and protein metabolism in liver disease. Seminars in Liver Disease 1991; 11: 265-277.

McGrotty YL, Ramsey IK, Knottenbelt CM. Diagnosis and management of hepatic copper accumulation in a Skye terrier. Journal of Small Animal Practice 2003; 44: 85-89.

Medina J, Moreno-Otero R. Pathophysiological basis for antioxidant therapy in chronic liver disease. Drugs 2005; 65: 2445-2461.

Meyer DJ. Hepatic pathology. In: Guilford WG, Center SA, Strombeck DR, et al, eds. Strombeck's Small Animal Gastroenterology, 3rd ed. Philadelphia, PA: WB Saunders Co, 1996; 633-653.

Meyer HP, Rothuizen J, Ubbink JB, et al. Increasing incidence of hereditary intrahepatic portosystemic shunts in Irish wolfhounds in the Netherlands 1984-1992. Veterinary Record 1995; 136(1): 13-16.

Meyer HP, Rothuizen J. Chronic hepatobiliary disease. In: Kelly NC, Wills JM, eds. BSAVA Manual of Companion Animal Nutrition and Feeding. Quedjeley, Gloucester, UK: BSAVA. 65-71.

Meyer HP. Chronic hepatic encephalopathy: Studies into the pathogenesis and treatment in the dog. PhD Thesis. State University of Utrecht, The Netherlands, 1998.

Meyer HP. Effects of BCAA-enriched infusions on the HPA axis in dogs with chronic HE. In: Chronic Hepatic Encepatholapthy: Studies Into The Pathogenesis And Treatment In The Dog. PhD Thesis, State University of Utrecht, The Netherlands, 1998a: 155-174.

Meyer HP. Effects of BCAA-enriched infusions on the HPA axis in dogs with chronic HE. In: Chronic Hepatic Encepatholapthy: Studies Into The Pathogenesis And Treatment In The Dog. PhD Thesis, State University of Utrecht, The Netherlands, 1998a: 155-174.

Meyer HP. Hepatic encephalopathy: An overview. In: Hill's European Symposium on Canine and Feline Liver Disease, Amsterdam, 2000, ISBN 0-9540567-0-1, 24-28.

Michel KE. Nutritional management of liver disease. Veterinary Clinics of North America: Small Animal Practice 1995; 25: 485-501.

Moon ML. Diagnostic imaging of portosystemic shunts. Seminars in Veterinary Medicine and Surgery: Small Animal 1990; 5: 120-126.

Morgan AG, Kelleher J, Walker BE, et al. Nutrition in cryptogenic cirrhosis and chronic aggressive hepatitis. Gut 1976; 17: 113-118.

Mullen KD, Weber FL. Role of nutrition in hepatic encephalopathy. Seminars in Liver Disease 1991; 11: 292-304.

Munoz SJ. Nutritional therapies in liver disease. Seminars in Liver Disease 1991; 11: 278-291.

Neer TM. A review of disorders of the gallbladder and extrahepatic biliary tract in the dog and cat. Canadian Journal of Veterinary Internal Medicine 1992; 6: 186-192.

Nishino M, Iimuro Y, Ueki T, et al. Hepatocyte growth factor improves survival after partial hepatectomy in cirrhotic rats suppressing apoptosis of hepatocytes. Surgery 2008; 144(3): 374-384.

NRC. (National Research Council.) Nutrient Requirements of Dogs and Cats. Washington, DC: National Academies Press, 2006.

Nyland TG, Mattoon JS, Wisner ER. Ultrasonography of the liver. In: Nyland TG, Mattoon JS, eds. Veterinary Diagnostic Ultrasound. Philadelphia, PA: WB Saunders Co, 1995; 52-73.

O'Keefe SF, El-Zayadi AR, Carraher TE, et al. Malnutrition and immunocompetence in patients with liver disease. Lancet 1980; 2: 615-617.

Owen OE, Reichle FA, Mozzoli MA, et al. Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis. Journal of Clinical Investigation 1981; 68: 240-252.

Partington BP, Biller DS. Hepatic imaging with radiology and ultrasound. Veterinary Clinics of North America: Small Animal Practice 1995; 25: 305-335.

Partington BP, Biller DS. Liver. In: Green RW, ed. Small Animal Ultrasound. Philadelphia, PA: Lippincott-Raven Publishers, 1996; 105-130.

Qiao ZK, Halliday ML, Coates RA, et al. Relationship between liver cirrhosis, death rate and nutritional factors in 38 countries. International Journal of Epidemiology 1988; 17: 414-418.

Remillard RL, Saker KE. Nutritional management of hepatic conditions. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine, 6th ed. St. Louis, MO: Elsevier Saunders, 2005; 574-577.

Riggio O, Merli M, Capocaccia L. The role of zinc in the management of hepatic encephalopathy. In: Bengtsson F, Jeppsson F, eds. Progress in Hepatic Encephalopathy. Boca Raton, FL: CRC Press Inc, 1991; 303-312.

Rolfe DS, Twedt DC. Copper-associated hepatopathies in dogs. Veterinary Clinics of North America: Small Animal Practice 1995; 25: 399-417.

Rothuizen J, Desmet VJ, Van Den Ingh T, et al. Sampling and handling of liver tissue. In: Rothuizen J, Bunch SE, Charles JA, et al, eds. WSAVA Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Disease. Philadelphia, PA: Elsevier Saunders, 2006; 5-14.

Rothuizen J, Meyer HP. History, physical examination, and signs of liver disease. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine: Diseases of the Dog and Cat. Philadelphia, PA: WB Saunders Co, 2000; 1272-1277.

Rothuizen J, Mol JA. The pituitary-adrenocortical system in canine hepatoencephalopathy. In: van Wimersma Greidanus TB, ed. Frontiers of Hormone Research. Basel, Karger, 1987; 28-36.

Rutgers C, Stradley RP, Rogers WA. Plasma amino acid analysis in dogs with experimentally induced hepatocellular and obstructive jaundice. American Journal of Veterinary Research 1987; 48: 696-702.

Scalfani L, Shimm P, Edelman J, et al. Protective effect of vitamin E in rats with acute liver injury. Journal of Parenteral and Enteral Nutrition 1986; 10: 184-187.

Schaeffer MC, Rogers QR, Buffington CA, et al. Long-term biochemical and physiologic effects of surgically placed portosystemic shunts in dogs. American Journal of Veterinary Research 1986; 47: 346-355.

Scherk MA, Center SA. Toxic, metabolic, infectious, and neoplastic liver diseases. In: Ettinger SJ, Feldman EC, eds. St. Louis, MO: Elsevier Saunders, 2010; 1672-1689

Schermerhorn T, Center SA, Dykes NL, et al. Characterization of hepatoportal microvascular dysplasia in a kindred of cairn terriers. Journal of Veterinary Internal Medecine 1996; 10: 219-230.

Schultheiss PC, Bedwell CL, Hamar DW, et al. Canine liver iron, copper, and zinc concentrations and association with histologic lesions. Journal of Veterinary Diagnostic Investigations 2002; 14(5): 396-402.

Simpson KW, Meyer DJ, Boswood A, et al. Iron status and erythrocyte volume in dogs with congenital portosystemic vascular anomalies. Journal of Veterinary Internal Medicine 1997; 11(1): 14-19.

Skeie B, Kvetan V, Gil KM, et al. Branch-chain amino acids: Their metabolism and clinical utility. Critical Care Medicine 1990; 18: 549-571.

Soden JS, Devereaux MW, Haas JE, et al. Subcutaneous vitamin E ameliorates liver injury in an in vivo model of steatocholestasis. Hepatology 2007; 46: 485-495.

Sokol RJ, Deveraux MW, O'Brien K, et al. Abnormal hepatic mitochondrial respiration and cytochrome C oxidase activity in rats with long-term copper overload. Gastroenterology 1993; 105: 178-187.

Sokol RJ, Devereaux MW, Traber MG, et al. Copper toxicity and lipid peroxidation in isolated rat hepatocytes: Effect of vitamin E. Pediatric Research 1989; 25: 55-62.

Sokol RJ, Hoffenberg EJ. Antioxidants in pediatric gastrointestinal disease. Pediatric Gastroenterology II. 1996; 43(2): 471-488.

Sokol RJ, McKim J, Goff M, et al. Vitamin E reduces oxidant injury to mitochondria and the hepatotoxicity of taurochenodeoxycholic acid in the rat. Gastroenterology 1998; 114: 164-174.

Sokol RJ, Twedt DC, McKim JM, et al. Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis. Gastroenterology 1994; 107: 1788-1798.

Spee B, Arends B, Ingh TSAGM, et al. Copper metabolism and oxidative stress in chronic inflammatory and cholestatic liver diseases in dogs. Journal of Veterinary Internal Medicine 2006; 20: 1085-1092.

Speeti M, Eriksson J, Saari S, et al. Lesions of subclinical Doberman hepatitis. Veterinary Pathology 1998; 35: 361-369.

Sterczer A, Meyer HP, Boswijk HC, et al. Evaluation of ammonia measurements in dogs with two analysers for use in veterinary practice. Veterinary Record 1999; 144(19): 523-526.

Stockhaus C, Van Den Ingh T, Rothuizen J, et al. A multistep approach in the cytological evaluation of liver biopsy samples of dogs with hepatic diseases. Veterinary Pathology 2004; 41(5): 461-470.

Stolz DB, Mars WM, Peterson BE, et al. Growth factor signal transduction immediately after two-thirds partial hepatectomy in the rat. Cancer Research 1999; 59(16): 3954-3960.

Strombeck DR, Harrold D, Rogers QR, et al. Plasma amino acids, glucagon, and insulin concentrations in dogs with nitrosamine-induced hepatic disease. American Journal of Veterinary Research 1983; 44: 2028-2036.

Strombeck DR, Harrold D, Rogers QR. Effects of catecholamines and ammonia on plasma and brain amino acids in dogs. American Journal of Physiology 1984; 247: E276-E283.

Strombeck DR, Rogers QR. Plasma amino acid concentrations in dogs with hepatic disease. Journal of the American Veterinary Medical Association 1978; 173: 93-96.

Su L-C, Owens CA, Zollman PE, et al. A defect of biliary excretion in copper-laden Bedlington terriers. American Journal of Physiology 1982a; 243: G231-G236.

Su L-C, Ravanshad S, Owens CA, et al. A comparison of copper-loading disease in Bedlington terriers and Wilson's disease in humans. American Journal of Physiology 1982; 243: G226-G230.

Swart GR, Zillikens MC, van Vuuve JK, et al. Effect of a late evening meal on nitrogen balance in patients with cirrhosis of the liver. British Medical Journal 1989; 299: 1202-1203.

Szatmari V, Rothuizen J. Ultrasonic identification and characterization of congenital portosystemic shunts and portal hypertensive disorders in dogs and cats. In: Rothuizen J, Bunch SE, Charles JA, et al, eds. WSAVA Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Disease. Philadelphia, PA: Elsevier Saunders, 2006; 15-39.

Teske E, Brinkhuis BG, Bode P, et al. Cytological detection of copper for the diagnosis of inherited copper toxicosis in Bedlington terriers. Veterinary Record 1992; 131: 30-32.

Thompson JSD, Schafer DR, Haun J, et al. Adequate diet prevents hepatic coma in dogs with Eck fistulas. Surgical Gynecology and Obstetrics 1986; 162: 126-130.

Thornburg LP, Beissenherz M, Dolan M, et al. Histochemical demonstration of copper-associated protein in the canine liver. Veterinary Pathology 1985; 22: 327-332.

Thornburg LP, Polley D, Dimmit R. The pathogenesis of copper-associated liver disease in dogs. Canine Practice 1985a; 12: 33-38.

Thornburg LP, Rottinghaus G, Dennis G, et al. The relationship between hepatic copper content and morphologic changes in the liver of West Highland white terriers. Veterinary Pathology 1996; 33: 656-661.

Thornburg LP, Rottinghaus G, Koch J, et al. High liver copper levels in two Doberman pinschers with sub-acute hepatitis. Journal of the American Animal Hospital Association 1984; 20: 1003-1005.

Thornburg LP, Rottinghaus G, McGowan M, et al. Hepatic copper concentrations in purebred and mixed-breed dogs. Veterinary Pathology 1990; 27: 81-88.

Thornburg LP, Shaw D, Dolan M, et al. Hereditary copper toxicosis in West Highland white terriers. Veterinary Pathology 1986; 23: 148-154.

Thornburg LP. Histomorphological and immunohistochemical studies of chronic active hepatitis in Doberman pinschers. Veterinary Pathology 1998; 35: 380-385.

Twedt DC, Sokol RJ, Devereaux MW, et al. Vitamin E protects against oxidative damage of bile acids in isolated hepatocytes. Journal of Veterinary Internal Medicine 1998; 12: 215.

Twedt DC, Sternlieb I, Gilbertson SR. Clinical, morphologic and chemical studies on copper toxicosis of Bedlington terriers. Journal of the American Veterinary Medical Association 1979; 175: 269-275.

Twedt DC, Webb CB, Tetrick MA. The effect of dietary vitamin E on the clinical laboratory and oxidant status of dogs with chronic hepatitis. Journal of Veterinary Internal Medicine 2003; 17: 418A.

Twedt DC. Copper hepatotoxicity in dogs: Pathophysiology, diagnosis and therapy. In: Proceedings. Ninth Annual Veterinary Medical Forum, American College of Veterinary Internal Medicine, Washington, DC, 1990: 169-172.

Uribe M. Treatment of portal systemic encephalopathy: The old and new treatments. In: Grisolia S, ed. Cirrhosis, Hepatic Encephalopathy, and Ammonium Toxicity. New York, NY: Plenum Press, 1990; 235-253.

Van De Sluis B, Rothuizen J, Pearson PL, et al. Identification of a new copper metabolism gene by positional cloning in a purebred dog population. Human Molecular Genetics 2002; 11: 165-173.

Watson PJ. Chronic hepatitis in dogs: A review of current understanding of the aetiology, progression, and treatment. The Veterinary Journal 2004; 167: 228-241.

Webb CB, Twedt DC, Meyer DJ. Copper-associated liver disease in Dalmatians: A review of 10 dogs 1998-2001. Journal of Small Animal Practice 2002; 16: 665-668.

Weber FL, Minco D, Fresard KM, et al. Effects of vegetable diets on nitrogen metabolism in cirrhotic subjects. Gastroenterology 1985; 89: 538-544.

Webster CRL, Cooper JC. Diagnostic approach to hepatobiliary disease. In: Bonagura JD, Twedt DC, eds. Kirk's Current Veterinary Therapy XIV. St. Louis, Mo: Saunders Elsevier 2009: 543-549.

Webster CRL. History, clinical signs, and physical findings in hepatobiliary disease. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine: Diseases of the Dog and Cat. St. Louis, MO: Elsevier Saunders, 2005; 1422-1434.

Weiss DJ, Armstrong PJ, Mruthyunjaya A. Anti-liver membrane protein antibodies in dogs with chronic hepatitis. Journal of Veterinary Internal Medicine 1995; 9: 267-271.

Wilson JD. Androgens. In: Goodman LS, Gillman A, Rall TW, et al, eds. The Pharmacological Basis of Therapeutics, 8th ed. New York, NY: Pergamon Press, 1990; 1413-1430.

WSAVA. (World Small Animal Veterinary Association Liver Standardization Group.) Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Diseases. New York, NY: Saunders Elsevier, 2006; 61.

Yu S, Gross KL. Moderate dietary vitamin C supplementation does not affect urinary calcium oxalate concentration in cats. Journal of Animal Physiology and Animal Nutrition (Berlin) 2005; 89: 428-429.

Yuzbasiyian-Gurkan V, Blanton SH, Cao Y, et al. Linkage of a microsatellite marker to the canine copper toxicosis locus in Bedlington terriers. American Journal of Veterinary Research 1997; 58: 23-27.

Yuzbasiyian-Gurkan V, Grider A, Nostrant T, et al. Treatment of Wilson's disease with zinc: X. Intestinal metallothionein induction. Laboratory Clinical Medicine 1992; 120: 380-386.

Zakim D. Metabolism of glucose and fatty acids by the liver. In: Zakim D, Boyer TD, eds. Hepatology: A Textbook of Liver Disease, 2nd ed. Philadelphia, PA: WB Saunders Co, 1982; 65-96.

Zakim D. Pathophysiology of liver disease. In: Smith LH, Thier SO, eds. Pathophysiology: The Biological Principles of Disease, 2nd ed. Philadelphia, PA: WB Saunders Co, 1985; 1253-1298.

Zieve L, Zieve FJ. The dietary prevention of hepatic coma in Eck fistula dogs: Ammonia and the carbohydrate to protein ratio. Hepatology 1987; 7: 196-198.


Box 68-1 Bibliography

Center SA, Randolph JF, Warner KL, et al. The effects of S-adenosylmethionine on clinical pathology and redox potential in the red blood cell, liver, and bile of clinically normal cats. Journal of Veterinary Internal Medicine 2005; 19: 303-314.

Maddison JE. Hepatic encephalopathy: Current concepts of the pathogenesis. Journal of Veterinary Internal Medicine 1992; 6: 341-353.

Meyer HP. Effects of BCAA-enriched infusions on the HPA axis in dogs with chronic HE. In: Chronic Hepatic Encepatholapthy: Studies into The Pathogenesis and Treatment in the Dog. PhD Thesis, State University of Utrecht, The Netherlands, 1998: 155-174.

Meyer HP. General discussion. In Chronic Hepatic Encephalopathy: Studies into the Pathogenesis and Treatment in the Dog. PhD Thesis, State University of Utrecht, The Netherlands, 1998: 177-179.

Meyer HP. Pathogenesis of HE: An overview. In: Chronic Hepatic Encepatholapthy: Studies into the Pathogenesis and Treatment in the Dog. PhD Thesis, State University of Utrecht, The Netherlands, 1998: 15-52.

Rothuizen J, Mol JA. The pituitary-adrenocortical system in canine hepatoencephalopathy. In: van Wimersma Greidanus TB, ed. Frontiers of Hormone Research. Basel, Karger, 1987; 28-36.

Taboada J, Dimski DS. Hepatic encephalopathy: Clinical signs, pathogenesis and treatment. Veterinary Clinics of North America: Small Animal Practice 1995; 25: 337-355.


Box 68-2 Bibliography

Dimski DS. Ammonia metabolism and the urea cycle: Function and clinical implications. Journal of Veterinary Internal Medicine 1994; 8: 73-78.


Box 68-3 Bibliography

Allen KGD, Twedt DC, Hunsaker HA. Tetramine cupruretic agents: A comparison in dogs. American Journal of Veterinary Research 1987; 48: 28-30.

Askari FK, Greenson J, Dick RD, et al. Treatment of Wilson's disease with zinc. XVIII. Initial treatment of the hepatic decompensation presentation with trientine and zinc. Journal of Laboratory and Clinical Medicine 2003; 142: 385-390.

Brewer GJ, Dick RD, Johnson VD, et al. The treatment of Wilson's disease with zinc. Journal of Laboratory and Clinical Medicine 1999; 134: 322-324.

Brewer GJ, Dick RD, Schall W, et al. Use of zinc acetate to treat copper toxicosis in dogs. Journal of the American Veterinary Medical Association 1992; 201: 564-568.

Brewer GJ. Zinc in the treatment of Wilson's disease: How it works (Letter to the Editor). Gastroenterology 1993; 104: 1568.

Center SA. Chronic liver diseases. In: Guilford WG, Center SA, Strombeck DR, et al, eds. Strombeck's Small Animal Gastroenterology, 3rd ed. Philadelphia, PA: WB Saunders Co, 1996; 705-765.

Jaffe I, Altman K, Merryman P. The antipyridoxine effects of penicillamine in man. Journal of Clinical Investigation 1964; 43: 1869-1873.

Rolfe DS, Twedt DC. Copper-associated hepatopathies in dogs. Veterinary Clinics of North America: Small Animal Practice 1995; 25: 399-417.

Twedt DC, Hunsaker HA, Allen KGD. Use of 2,3,2-tetramine as a hepatic copper chelating agent for treatment of copper hepatotoxicosis in Bedlington terriers. Journal of the American Veterinary Medical Association 1988; 92: 52-58.

Twedt DC. Copper hepatotoxicity in dogs: Pathophysiology, diagnosis and therapy. In: Proceedings. Ninth Annual Veterinary Medical Forum, American College of Veterinary Internal Medicine, Washington, DC, 1990: 169-172.


Box 68-4 Bibliography

Blei AT, Cordoba J. Hepatic encephalopathy. American Journal of Gastroenterology 2001; 96(7): 1968-1976.


Box 68-5 Bibliography

Boigk G, Stroedter L, Herbst H, et al. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats. Hepatology 1997; 26: 643-649.

Campos R, Garrido A, Guerra R, et al. Silybin dehemisuccinate protects against glutathione depletion and lipid peroxidation induced by acetaminophen on rat liver. Planta Medica 1989; 5: 417-419.

Center SA. Metabolic, antioxidant, nutraceutical, probiotic, and herbal therapies relating to the management of hepatobiliary disorders. Veterinary Clinics of North America: Small Animal Practice 2004; 34, 67-172.

Center SA, Warner KL, McCabe J, et al. Evaluation of the influence of S-adenosylmethionine on systemic and hepatic effects of prednisolone in dogs. American Journal of Veterinary Research 2005; 66: 330-341.

Dhiman RK, Chawla YK. Herbal medicines for liver diseases. Digestive Disease Science 2005; 50: 1807-1812.

Hanje AJ, Fortune B, Song M, et al. The use of selected nutrition supplements and complementary and alternative medicine in liver disease. Nutrition in Clinical Practice 2006; 21: 255-272.

Levy C, Seeff LD, Lindor KD. Use of herbal supplements for chronic liver disease. Clinical Gastroenterology and Hepatology 2004; 2: 947-956.

Lieber CS, Leo MA, Cao Q, et al. Silymarin retards the progression of alcohol-induced hepatic fibrosis in baboons. Journal of Clinical Gastroenterology 2003; 37: 336-339.

Loguercio C, Federico A. Oxidative stress in viral and alcoholic hepatitis. Free Radical Biology & Medicine 2003; 34: 1.

Montanini S, Sinardi D, Pratico C, et al. Use of acetylcysteine as the life-saving antidote in Amanita phalloides (death cap) poisoning. Case report on 11 patients. Arzneimittelforschung 1999; 49: 1044.

Muriel P, Mourelle M. Prevention by silymarin of membrane alterations in acute CCl4 liver damage. Journal of Applied Toxicology 1990; 10: 275-279.

Paulova J, Dvorak M, Kolouch F, et al. Evaluation of the hepatoprotective and therapeutic effects of silymarin in liver damage experimentally produced with carbon tetrachloride in dogs. Veterinary Medicine (Praha) 1990; 35: 629-635.

Pradhan SC, Girish C. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian Journal of Medical Research 2006; 124: 491-504.

Rothuizen J. General principles in the treatment of liver disease. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine, 6th ed. St. Louis, MO: Elsevier Saunders, 2005; 1435-1442.

Verma S, Thuluvath PJ. Complementary and alternative medicine in hepatology: Review of the evidence of efficacy. Clinical Gastroenterology and Hepatology 2007; 5: 408-416.

Vogel G, Tuchweber B, Trost W, et al. Protection by silibinin against Amanita phalloides intoxication in beagles. Toxicology and Applied Pharmacology 1984; 73: 355.

Wallace KP, Center SA, Hickford FH, et al. S-adenosyl-L-methionine (SAMe) for the treatment of acetaminophen toxicity in a dog. Journal of the American Animal Hospital Association 2002; 38: 246.

Wang M, Grange LL, Tao J. Hepatoprotective properties of Silybum marianum herbal preparation on ethanol induced liver damage. Fitoterapia 1996; 67: 167-171.

Webb CB, Twedt DC, Fettman MJ, et al. S-adenosylmethionine (SAMe) in a feline acetaminophen model of oxidant injury. Journal of Feline Medicine and Surgery 2003; 5: 69-75.